Attend the Virtual Global Study Fair | Register Now Attend the Virtual Global Study Fair | Register Now

We have 5 multiple sclerosis PhD Projects, Programmes & Scholarships

Discipline

Discipline

All disciplines

Location

Location

All locations

Institution

Institution

All Institutions

PhD Type

PhD Type

All PhD Types

Funding

Funding

All Funding


multiple sclerosis PhD Projects, Programmes & Scholarships

We have 5 multiple sclerosis PhD Projects, Programmes & Scholarships

PhD saved successfully

A Cell Interactome Approach to Model, Characterise and understand Novel Mechanisms of Disease in Progressive Multiple Sclerosis

(co-supervised with A Nicaise and I Mohorianou). Recent work suggests that cellular ageing, known as senescence, of endogenous stem-like cells in the brain may contribute to the chronic inflammation and neurodegeneration seen in people with progressive multiple sclerosis (PMS). Read more

The Survivin Interactome in Health and Disease

Survivin is a small protein that is essential for life but that also contributes to disease, most notably cancer, in which its abnormal overexpression is linked to therapeutic resistance and metastasis. Read more

Brain tissue mechanics: constitutive modeling of degeneration and dynamics

The aim of this project is to evaluate the mechanics of grey and white matter found in the brain during health & disease and effective methods by which to model disease mechanics and progression. Read more

Optimising functional independence across the life and healthspan using neurostimulation

Neuroplasticity is integral to recovery and maintenance of functional independence as we age, and even more crucial in individuals with developmental disorders such as Cerebral Palsy and those with injuries to their brain and/or central nervous system (Spinal Cord Injury, Stroke, MS). Read more

3D-Printing of implantable devices for the treatment of chronic conditions

Non-adherence to treatment costs the NHS more than £500M each year. Adherence is especially important when treating patients with chronic conditions that require lifetime pharmacological treatment, such as schizophrenia, Parkinson’s disease, HIV and Alzheimer’s disease. Read more
  • 1

Filtering Results